Evidence map›Paper›PMID 29075576›Full record

ArticleBrain and behavior2017

Cost benefits of rapid recanalization using intraarterial thrombectomy.

Hye Seon Jeong, Jong Wook Shin, Hyon-Jo Kwon, Hyeon-Song Koh, Hae-Sung Nam, Hee Seon Yu, Na Young Yoon, Jei Kim

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hye Seon JeongDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.
Jong Wook ShinDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.
Hyon-Jo KwonDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.
Hyeon-Song KohDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.
Hae-Sung NamDepartment of Preventive Medicine School of Medicine Chungnam National University Daejeon Korea.
Hee Seon YuDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.ORCID 0000-0001-7866-4411
Na Young YoonDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.
Jei KimDaejeon-Chungnam Regional Cerebrovascular Center Hospital and School of Medicine Chungnam National University Daejeon Korea.ORCID 0000-0002-0718-9251
Chungnam National University Hospital · KRChungnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThrombolytic therapy is associated with favorable clinical outcomes after successful and rapid recanalization in patients with acute ischemic stroke. This study aimed to evaluate the cost benefits and clinical outcomes at 1 year after intraarterial thrombectomy (IAT) by the rapidity of the successful recanalization. MATERIALS &

methodsClinical outcomes of and medical costs incurred by 230 patients with acute ischemic stroke who underwent IAT were compared by the rapidity from symptom onset to successful recanalization (2b/3 thrombolysis in cerebral infarction grade): ≤6-hr (

resultsPatients in the ≤6-hr group showed higher functional independence (≤6-hr, 70%; >6-hr, 40%; no-recanalization, 6%,

conclusionsRapid and successful recanalization of the occluded intracranial vessels within 6 hr after the onset of symptoms resulted in markedly higher cost utility and functional independence at 1 year post-IAT.

Indexed as

Brain IschemiaStrokeThrombectomyAgedCerebral ArteriesCerebral RevascularizationCost-Benefit AnalysisFemaleFibrinolytic AgentsHumansMaleMiddle AgedRepublic of KoreaSurvival AnalysisSymptom AssessmentThrombolytic TherapyFibrinolytic Agentscost‐utility analysisintraarterial thrombectomyonset‐to‐recanalization timequality adjusted‐life year

Identifiers

PMID29075576
PMCPMC5651400
OpenAlexW2751440839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.